Symptom Clusters in Children With Exacerbation-prone Asthma
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Pediatric participants with exacerbation-prone asthma will receive an intramuscular injection
of triamcinolone acetonide and will be followed for 48 weeks. The study visit 2 weeks after
the injection will assess the response to the study medication, while the remaining study
visits will examine the temporal stability of the symptom clusters.